GlassScriptPhysician profile
Laith Jazrawi
NPI 1316933724
$120,343.63
in general payments reported to CMS, 2019-2025
14 companies · $72K in 2025
The $72K reported for 2025 was more than what 96% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,375 · 2020: $2,099 · 2021: $1,260 · 2022: $1,613 · 2023: $3,494 · 2024: $31K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $5,687 · Food and Beverage: $3,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,135.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,375.00 |
| Travel and Lodging | $5,687.26 |
| Food and Beverage | $3,799.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $66,792.74 | 2019-2025 | Spatial Frame, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Miach Orthopaedics, INC. | $25,997.05 | 2024-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $9,846.53 | 2019-2021 | |
| Medical Device Business Services, INC. | $9,458.10 | 2023-2025 | Healix Knotless Peek, Rigidloop |
| Arthrex, INC. | $3,090.13 | 2019-2025 | |
| Suvon Surgical LLC | $1,966.22 | 2022-2025 | |
| Horizon Therapeutics Plc | $986.61 | 2019-2022 | |
| Brixton Biosciences, INC. | $850.00 | 2025 | Neural Ice |
| Joint Restoration Foundation, INC. | $537.16 | 2019-2025 | |
| Depuy Synthes Sales INC. | $460.00 | 2019-2025 | Monovisc, Na, Peak |
| Lifenet Health | $190.87 | 2019-2022 | |
| Lazurite INC. | $91.55 | 2023 | |
| Brainlab, INC. | $55.00 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Linvatec Corporation | $21.67 | 2023 | Hall Power, Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,230.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laith Jazrawi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.